| Stage | MSM | % of rev | ALSN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $1.6B | 100.00% | ALSN ×1.45 |
| Gross profit | $439M | 40.64% | $515M | 32.89% | MSM +7.8pp |
| Operating income | $73M | 6.75% | $291M | 18.58% | ALSN +11.8pp |
| Pre-tax income | $64M | 5.96% | $228M | 14.56% | ALSN +8.6pp |
| Net income | $48M | 4.44% | $181M | 11.56% | ALSN +7.1pp |
| Stage | MSM | ALSN | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $1.6B100.00% | ALSN ×1.45 |
| Gross profit | 40.64%$439M | 32.89%$515M | MSM +7.8pp |
| Operating income | 6.75%$73M | 18.58%$291M | ALSN +11.8pp |
| Pre-tax income | 5.96%$64M | 14.56%$228M | ALSN +8.6pp |
| Net income |
| 4.44%$48M |
| 11.56%$181M |
| ALSN +7.1pp |
No shared counterparties.